All News
Stay up to date with all of Bicycle’s latest news.
Press Releases
201821 November, 2018
Bicycle Therapeutics to Present at 30th Annual Piper Jaffray Healthcare Conference
14 November, 2018
Bicycle Therapeutics Named Best New Drug Developer at 2018 World ADC Awards
12 November, 2018
Bicycle Therapeutics’ Founder Sir Gregory Winter to Deliver Keynote Address at the 2018 Protein and Antibody Engineering (PEGS) Summit Europe
8 November, 2018
Bicycle Therapeutics to Present at Jefferies 2018 London Healthcare Conference
1 November, 2018
Bicycle Therapeutics Strengthens Leadership Team with Appointment of Phil Jeffrey, Ph.D., as SVP Pre-Clinical Development
17 October, 2018
Bicycle Therapeutics Announces Presentation at the Royal Society
3 October, 2018
Bicycle Therapeutics’ Founder Sir Gregory Winter Awarded Nobel Prize in Chemistry
31 May, 2018
Bicycle Therapeutics Announces Formation Of Scientific Advisory Board
29 May, 2018
Bicycle Therapeutics to Present at Jefferies 2018 Global Healthcare Conference
25 May, 2018
Bicycle Therapeutics Announces Clinical Milestone & Expands Collaboration with Thrombogenics
24 May, 2018
Bicycle Therapeutics Expands Strategic Partnership with AstraZeneca
20 March, 2018
Bicycle Therapeutics Promotes Michael Skynner, Ph.D., to Chief Operating Officer
6 March, 2018
Bicycle Therapeutics to Present at Cowen and Company 38th Annual Health Care Conference
13 February, 2018
Bicycle Therapeutics and Cancer Research UK announce initiation of first clinical study of a bicyclic peptide (Bicycle®)
4 January, 2018
Bicycle Therapeutics secures an Innovate UK grant to develop the next generation of antibiotics
20176 December, 2017
Bicycle Therapeutics and Cancer Research UK named Best Partnership Alliance of the Year at 2017 Scrip Awards
26 October, 2017
Bicycle Therapeutics to present preclinical data on lead molecule BT1718 at the AACR-NCI-EORTC International Cancer Conference
12 October, 2017
Bicycle Therapeutics recognised with multiple biotech industry awards
26 September, 2017
Bicycle therapeutics strengthens senior management team with appointment of Maria Koehler, M.D., Ph.D., As Chief Medical Officer
6 September, 2017
Bioverativ and Bicycle Therapeutics enter into strategic research collaboration to develop therapies for Haemophilia and Sickle Cell Disease
1 August, 2017
Bicycle Therapeutics expands leadership team with appointment of Lee Kalowski as Chief Financial Officer
1 June, 2017
Bicycle Therapeutics closes £40 million ($52 million) in Series B financing to advance clinical pipeline
20 April, 2017
Bicycle Therapeutics announces a candidate preclinical milestone in its ophthalmology alliance with Thrombogenics
3 April, 2017
Bicycle Therapeutics announces presentations at the 2017 American Association for Cancer Research Annual Meeting
29 March, 2017
Bicycle Therapeutics is named winner of Business Weekly’s Disruptive Technology Award 2017
2 March, 2017
Bicycle Therapeutics to present at Cowen and Company 37th Annual Health Care Conference
5 January, 2017
Bicycle Therapeutics appoints Nicholas Keen, Ph.D., as Chief Scientific Officer
201621 December, 2016
Bicycle Therapeutics is named winner of Fierce Innovation Award
15 December, 2016
Cancer Research UK and Bicycle Therapeutics collaborate to trial new therapy for advanced solid tumours
1 December, 2016
Bicycle Therapeutics announces broad partnership with AstraZeneca to develop bicyclic peptides (Bicycles®)
28 November, 2016
Bicycle Therapeutics to present preclinical data at the 28th EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium
11 October, 2016
Bicycle Therapeutics appoints Peter U. Park, Ph.D., as Vice President of Oncology Research
18 July, 2016
Bicycle Therapeutics appoints Stephen J. Hoffman, M.D., Ph.D., as Board Chairman
5 May, 2016
Bicycle Therapeutics strengthens product development capabilities with key leadership appointments
201521 September, 2015
Bicycle Therapeutics announces appointment of CEO
2014
